A major advance in cancer investigation is arising with the use of mini-antibodies to re-engage mutated p53. This crucial malignant protector protein is frequently disabled in many types of tumors, leading uncontrolled https://bookmark-nation.com/story21765990/mini-antibodies-revive-p53-the-new-approach-for-cancer-treatment